Article Text

Download PDFPDF
Rosuvastatin prevented major cardiovascular events in people with elevated C-reactive protein

Statistics from


  • Source of funding: AstraZeneca.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.